Neudle.com: Parkinson disease risk factors for

Differential
(Click to cross reference)

advances in neurology

adverse drug reaction

alternating hemiplegia

alternating hemiplegia of childhood

alternative medicine

Alzheimer's disease

amygdala

amyotrophic lateral sclerosis

anisocoria

anosmia

anticholinergic drugs

anticipation

anticoagulant, complications of

anticonvulsants, effectiveness

anticonvulsants, selection of

antihypertensive

aortic valve, lesion of

attention deficit disorder with hyperactivity

atypical

autonomic dysfunction

basal ganglia, infarction

brain transplantation

brainstem, vascular malformation of

CAT scan, stereotactic localization

cavernous hemangioma

cerebellar hemorrhage

cerebrovascular accident

cerebrovascular disease

cerebrovascular disease, risk factors in

conjunctival injection

controversies in neurology

copper

coprolalia

coronary artery disease

cortical-basal ganglionic degeneration

creatine phosphokinase(CPK)elevated

DATATOP study

degenerative diseases of CNS

developmental retardation

developmental venous anomalies

diagnostic criteria

diet

differential diagnosis

dopaminergic dysfunction

dopaminergic neurons

drug abuse

drug induced neurologic disorders

Durett hemorrhages

dyskinesia

dystonia

dystonia, drug induced

echocardiogram

echocardiogram, transthoracic

epidemiology of neurology

eye movement, disorders of

fibrinolytic agents, complications

fine motor function, impaired

genetic neurologic disorders

genetic testing

Gilles de la Tourette syndrome

headache, prophylaxis

headache, severe

headache, treatment of

headache, unilateral

hearing loss

heavy metal intoxication

hepatitis

hepatitis B virus

hepatitis C virus

heralding manifestation

iatrogenic neurologic disorders

industrial neurologic disorders

insecticides

intellectual deficit

intracerebral hemorrhage

intracerebral hemorrhage, causes of

intracerebral hemorrhage, clot evacuation

intracerebral hemorrhage, incidence of

intracerebral hemorrhage, lobar

intracerebral hemorrhage, recurrent

intracerebral hemorrhage, treatment of

L-dopa, drug interactions with and side effects of

lead and the nervous system

Lewy body disease, diffuse

life expectancy

locus ceruleus, lesion of

malformation, vascular

malformation, vascular, cerebral

manganese intoxication

marche a petits pas

marihuana

masked facies

meningitis, carcinomatous

mental status, abnormal

mesial temporal sclerosis

mitochondrial disease

mitral valve lesion

mitral valve regurgitation

molecular genetics

monoamine oxidase inhibitors

mortality

motor neuron disease

movement disorder

movement disorder, extrapyramidal

movement disorder, hyperkinetic

movement disorder, psychogenic

MPTP

MRI

MRI, abnormal

MRI, contrast enhanced

MRI, functional

MRI, incidental finding

MRI, susceptibility weighted

MRS

multiple sclerosis

nabiximols

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS, hemorrhagic

neoplasm, metastatic to CNS-hemorrhage into

neoplasm, primary of CNS

neoplasm, primary of CNS-hemorrhage in

nerve growth factor

neuroleptic

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic disease

neurologic disease, diagnoses of

neurologic examination, focal

neurologic signs

neuronal degeneration

neurons

neuropathology

neuropathology, brain

neuropathy

neuroprotective agents

neurotoxic

neurotoxin

nigrostriatal pathway

nonsteroidal anti-inflammatory drug

nystagmus

nystagmus, monocular

obsessive-compulsive disorder

occupational neurologic disorders

old age, neurology of

oopherectomy

optic atrophy

oxidative phosphorylation

oxidative phosphorylation defect

Parkinson disease, arteriosclerotic

Parkinson disease, asymmetric onset

Parkinson disease, classification

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, freezing phenomena in

Parkinson disease, heterogeneity of

Parkinson disease, incidence

Parkinson disease, intractable

Parkinson disease, late onset

Parkinson disease, L-dopa nonresponsive

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, presymptomatic detection

Parkinson disease, prognosis of

Parkinson disease, racial prevalence

Parkinson disease, subtypes

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, young onset

Parkinsonism syndrome

paroxysmal hemiplegia

paroxysmal neurologic deficits

poison, organophosphate

postural abnormality

practice guidelines

pramipexole

precipitating factors

preclinical

premarin

prevention of neurologic disorders

PRKN gene

prognosis

progressive neurologic disorder

progressive supranuclear palsy

psychiatric disorder

psychiatric problems in neurologic disorders

psychosis

psychosomatic disease

ptosis

ptosis, unilateral

pyramidal tract dysfunction

radiation therapy, stereotactic

radiation therapy, sterotactic, complications

radiotracer imaging

raphe nuclei

rapid onset dystonia parkinsonism

rapidly progressing neurologic illness

risk-benefit assessment

rosacea

safety

seizure

seizure, drug resistance

seizure, intractable

seizure, intractable, treatment of

seizure, medication failure

seizure, surgical treatment of

seizure, treatment of

seizure, treatment of, polytherapy

seizure, treatment, adjunctive therapy

sensorineural hearing loss

sham surgery

sinemet

single photon emission computed tomography

sinusitis

skin, lesions in neurologic disorders

sleep

sleep pathology and physiology

smell

Smell Identification Test

solvent

spasticity

spasticity, treatment of

stem cell transplantation

stereotaxic surgery

stimulation, deep brain

stimulation, thalamic

substantia nigra

substantia nigra tissue

subthalamic nucleus

subthalamic nucleus deep brain stimulation

tic, classification of

tic, motor

tic, sensory

tic, vocal

tic-like movement disorder

toxins, nervous system

treatment of neurologic disorder

tremor

tremor, resting

tremor, thalamic stimulation for suppression of

trichloroethylene

tricuspid valve, lesion of

triptans

twins

urinary incontinence

vagus nerve stimulation

vitamin supplementation

welder

Showing articles 50 to 100 of 7887 << Previous Next >>

Parkinson's Disease
NEJM 339:1044-1053,1130-1143, Lang,A.E.&Lozano,A.M., 1998

The Risk of Parkinson's Disease with Exposure to Pesticides, Farming, Well Water, and Rural Living
Neurol 50:1346-1350, Gorell,J.M.,et al, 1998

Occupational Exposures to Metals as Risk Factors for Parkinson's Disease
Neurol 48:650-658, Gorell,J.M.,et al, 1997

Diet and Parkinson's Diseae I:A Possible Role for the Past Intake of Specific Foods and Food Groups
Neurol 47:636-643, Hellenbrand,W.,et al, 1996

A 60-Year-Old Man with Parkinson's Disease
JAMA 275:716-722, Olanow,C.W., 1996

Generalized Mitochondrial Dysfunction in Parkinson's Disease Detected by Magnetic Resonance Spectroscopy of Muscle
Neurol 45:2097-2099, Penn,A.M.W.,et al, 1995

Apolipoprotein E Genotype in Diverse Neurodegenerative Disorders
Ann Neurol 38:131-135, Schneider,J.A.,et al, 1995

Kindreds of Dominantly Inherited Parkinson's Disease:Keys to the Riddle
Ann Neurol 38:355-356, Duvoisin,R.C.&Golbe,L.I., 1995

A Greek-American Kindred with Autosomal Dominant, Levodopa-Responsive Parkinsonism and Anticipation
Ann Neurol 38:373-378, 3551995., Markopoulou,K.,et al, 1995

Cigarette Smoking and Protection from Parkinson's Disease:False Association or Etiologic Clue?
Neurol 45:1041-1051, Morens,D.M.,et al, 1995

Oxidative Damage in Neurodegenerative Disease
Lancet 344:796-798, Jenner,P., 1994

Increased Risk of Parkinson's Disease in Parents and Siblings of Patients
Ann Neurol 36:659-661, Payami,H.,et al, 1994

Growth Factors:Potential Therapeutic Applications in Neurology
JNNP 54:1445-1450, Drago,J.,et al, 1994

Identical Twins with Similar Onset of Parkinson's Disease:A Case Report
Neurol 43:1159-1161, Pahwa,R.,et al, 1993

Parkinson's Disease:A Test of the Multifactorial Etiologic Hypothesis
Neurol 43:1173-1180, Semchuk,K.M.,et al, 1993

Environmental Causation of Parkinson's Disease
Arch Neurol 50:651-652, Rajput,A.H., 1993

The Nonenvironmental Basis for Rising Mortality from Parkinson's Disease
Arch Neurol 50:653-656, Riggs,J.E., 1993

Risk Factors for Parkinson's Disease
Neurol 43:1693-1697, 16411993., Hubble,J.P.,et al, 1993

Environmental Antecedents of Young-Onset Parkinson's Disease
Neurol 43:1150-1158, Butterfield,P.G.,et al, 1993

Mitochondrial Involvement in Parkinson's Disease:The Controversy Continues
Neurol 43:2170-2172, DiMauro,S., 1993

Parkinson's Disease and Exposure to Agricultural Work and Pesticide Chemicals
Neurol 42:1328-1335, Semchuk,K.M.,et al, 1992

Stroke and Parkinson's Disease
Stroke 23:839-842, Levine,R.L.,et al, 1992

The Free Radical Hypothesis in Idiopathic Parkinsonism:Evidence Against It
Ann Neurol 32:799-803, Calne,D.B., 1992

The Oxident Stress Hypothesis in parkinson's Disease:Evidence Supporting it
Ann Neurol 32:804-812, Fahn,S.&Cohen,G., 1992

Environmental Risk Factors in Siblings with Parkinson's Disease
Arch Neurol 48:287-289, Wong,G.F.,et al, 1991

Intracerebral Hemorrhage
Stroke 22:684-691, Feldmann,E., 1991

The Epidemiology of Parkinson's Disease, A Case-Control Study of Young-Onset and Old-Onset Patients
Arch Neurol 48:903-907, Stern,M.,et al, 1991

Mitochondrial Oxidative Phosphorylation Defects in Parkinson's Disease
Ann Neurol 30:332-339, 3301991., Shoffner,J.M.,et al, 1991

Environmental Risk Factors in Parkinson's Disease
Neurol 40:1218-1221, Koller,W.,et al, 1990

Environmental Factors and Parkinson's Disease:A Case-Control Study in China
Neurol 39:660-664, Tanner,C.M.,et al, 1989

Current Theories on the Cause of Parkinson's Disease
JNNP Suppl (June) 52:13-17989., Langston,J.W., 1989

Did Leonardo Describe Parkinson's Disease?
NEJM 320:593, Calne,D.B.,et al, 1989

Comparison of the Prevalence of Parkinson's Disease in Black Populations in the Rural US & Nigeria
Neurol 38:645-646, Schoenberg,B.S.,et al, 1988

Update on Parkinson Disease
NY State J Med, 87:147-1531987., Lieberman,A.N., 1987

The Neuroleptic Malignant Syndrome:Agent and Host Interaction
Acta Psychiatr Scand 73:337-347, Shaley,A.&Munitz,H., 1986

Aetiology of Parkinson's Disease
Lancet 2:1457-1459, Calne,D.B.,et al, 1983

Seizures, Driver Licensure, and Medical Reporting
Neurol 104:e213459, Tolchin,B.,et al, 2025

A Toddler with Acute-Onset Hypotonia, Areflexia, and Ataxia
Neurol 104:e213593, Pence, K.L. &Clark, R.A., 2025

Low Hemoglobin Causes Intracerebral Hemorrhage Outcomes
Stroke 56:1234-1242, Cottarelli,A., et al, 2025

Clinicopathologic Conference, Cryptococcus Neoformans and Cushings Syndrome
NEJM 392:1847-1856, Case 13-2025, 2025

Association Between Cerebral Amyloid Angiopathy and Nontraumatic Subdural Hemorrhage
Neurol 104:e213614, Andres,W.,et al, 2025

Postprocedural Brachial Neuritis:Clinical, Electrodiagnostic, and Neuroimaging Features
AJNR 46:1050-1055, Ambati,V.S.,et al, 2025

Wildfire Smoke Exposure and Incident Dementia
JAMA Neurol 82:40-48, Elser,H.,et al, 2025

Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025

Severe Myotonic Crisis Resembling Malignant Hyperthermia
Neurol 104:e213497, Wadhwani,A.R.,et al, 2025

Inebilizumab for Treatment of IgG4-Related Disease
NEJM 392:1168-1177, Stone,J.H.,et al, 2025

Beyond Glucocorticoids for IgG4-Related Disease
NEJM 392:1232-1233, Spiera,R., 2025

RNF213 Polymorphisms in Intracranial Artery Dissection
Genes doi.org/10.3390/genesis 15060725, Zedde,M.,et al, 2024

Optimal Timing of Anticoagulation after Acute Ischaemic Stroke with Atrial Fibrillation (OPTIMAS): A Multicentre, Blinded-Endpoint, Phase 4, Randomised Controlled Trial
Lancet 404:1731-1741, Werring,D.J.,et al, 2024

Chronic Immunotherapy for Myasthenia Gravis
www.UptoDate.Com, Bird,S.J., 2024

Showing articles 50 to 100 of 7887 << Previous Next >>